NCT00188682View on ClinicalTrials.gov

Breast Study to Determine the Ability of Non-Invasive Optical Transillumination Spectroscopy to Predict Breast Density.

CompletedOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

March 31, 2000

Study Completion Date

September 30, 2003

Conditions

Breast Cancer

Trial Locations (1)

M5G 2M9

Ontario Cancer Institute, Princess Margaret Hospital, Toronto

All Listed Sponsors

collaborator

United States Department of Defense

FED

lead

University Health Network, Toronto

OTHER

NCT00188682 - Breast Study to Determine the Ability of Non-Invasive Optical Transillumination Spectroscopy to Predict Breast Density. | Biotech Hunter | Biotech Hunter